THOMAS E SHENK
CIK 1204362 · last filed 2025-06-16
THOMAS E SHENK is a corporate insider who has filed 34 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for MGTX, was dated Jun 16, 2025. Across all open-market trades the lifetime net is −$200.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.63M
7
34
-$200.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MGTX | Director | 157,476 | $9.59 | $1.51M | -$200.0K | 10 | 2025-06-16 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Director | 10,000 | — | — | $0 | 4 | 2018-05-24 |
| Kadmon Holdings, Inc. (KDMN) Delisted | Director | — | $9.50 | — | $0 | 2 | 2017-06-30 |
| MRK | Director | 1,000 | $119.05 | $119.0K | $0 | 5 | 2011-05-31 |
| Merck & Co., Inc. (MRKpB) Delisted | Director | 1,000 | — | — | $0 | 3 | 2010-08-06 |
| CV THERAPEUTICS INC (CVTX) Delisted | Director | 8,500 | — | — | $0 | 4 | 2009-04-16 |
| CELL GENESYS INC (CEGE) Delisted | Director | 32,000 | — | — | $0 | 5 | 2008-07-01 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-16 | MGTX | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | MGTX | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | MGTX | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | MGTX | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | MGTX | Grant (A) | — | $0 | EDGAR |
| 2020-07-22 | MGTX | Sell (S) | −6,667 | -$100.0K | EDGAR |
| 2020-06-04 | MGTX | Grant (A) | — | $0 | EDGAR |
| 2020-05-13 | MGTX | Sell (S) | −2,184 | -$32.8K | EDGAR |
| 2020-04-22 | MGTX | Sell (S) | −4,482 | -$67.2K | EDGAR |
| 2019-06-21 | MGTX | Grant (A) | — | $0 | EDGAR |